Skip to main content

Table 4 mortality associated factors by univariate and multivariate COX regression analysis in cirrhotic patients

From: Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort study

 

Univariate

 

Multivariate

(SATI)

 

Multivariate

(Low SATI)*

 

Characteristics

HR (95%CI)

p-value

HR (95%CI)

p-value

HR (95%CI)

p-value

Age

1.205(0.989–1.063)

0.168

    

Gender

1.935(0.857–4.372)

0.112

    

Etiologic cause

Hepatitis B

1.104(0.533–2.288)

0.790

    

Hepatitis C

1.553(0.369–6.537)

0.548

    

Alcohol

1.755(0.670–4.602)

0.253

    

Autoimmune

0.457(0.062–3.386)

0.444

    

Others

0.656(0.267–1.615)

0.359

    

Laboratory date

Hemoglobin

0.986(0.963–1.010)

0.259

    

Platelet count

0.998(0.990–1.005)

0.585

    

Total bilirubin

1.008(0.977–1.040)

0.625

    

Serum albumin

0.891(0.820–0.968)

0.006

    

PT

1.197(1.003–1.430)

0.047

    

Child-Pugh score

1.493(1.195–1.864)

< 0.001

1.385(1.088–1.765)

0.008

1.383(1.099–1.740)

0.006

MELD score

1.173(1.014–1.358)

0.032

    

PVT

0.941(0.428–2.066)

0.879

    

Ascites

1.628(0.777–3.411)

0.196

    

NSBB used

0.752(0.363–1.558)

0.443

    

Body Composition

BMI

0.856(0.757–0.967)

0.013

    

SATI

0.958(0.937–0.980)

< 0.001

0.965(0.944–0.986)

0.001

  

VATI

0.972(0.951–0.994)

0.011

    

TATI

0.980(0.969–0.991)

< 0.001

    

Low SATI*

4.179(1.846–9.459)

0.001

  

3.422(1.489–7.864)

0.004

  1. Abbreviations: CI, confidence interval; HR, hazard ratio; PT, prothrombin time; MELD, Model For End Stage Liver Disease; PVT, portal vein thrombosis; NSBBs, nonselective beta-receptor blockers; BMI, body mass index; SATI, subcutaneous adipose tissue index; VATI, visceral adipose tissue index; TATI, total adipose tissue index
  2. *Defined as SATI < 30.15 cm2/m2 for male and < 39.82 cm2/m2 for female